| Serial Number | 79025533 |
| Word Mark | KRINGLE PHARMA |
| Filing Date | Monday, November 14, 2005 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Saturday, November 14, 2015 |
| Registration Number | 3324812 |
| Registration Date | Tuesday, October 30, 2007 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 14, 2007 |
| Indication of Colors claimed | The color(s) dark blue, light blue, black and white is/are claimed as a feature of the mark. |
| Description of the Colors Claimed | The colors dark blue and light blue appear in the design of the overlapping partial circles appearing above the wording KRINGLE PHARMA, getting lighter from left to right. The color dark blue appears in the wording KRINGLE PHARMA, and the color white appears in the background. |
| Disclaimer with Predetermined Text | KRINGLE PHARMA |
| Goods and Services | Pharmaceutical veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases and cancer; sanitary preparations for medical use; central nervous system stimulants; stimulants in the nature of hair growth stimulant; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; preparations acting on the peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; pharmaceutical preparations for the treatment of autonomic nervous system diseases; antispasmodics; diaphoretics; pharmaceutical preparations for the treatment of sensory organs diseases; ophthalmic preparations; preparations for otic and nasal use, namely, nasal spray preparations, ear drops; antiallergic medications; antihistamines; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; pharmaceutical preparations for the treatment of vascular and venous diseases; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical products for treating respiratory diseases; respiratory stimulants; anti-cough drops; anti-tussive expectorants; pharmaceutical preparations for the treatment of disease affecting digestive organs; gastrointestinal cleaning agents; evacuants; pharmaceutical preparations for oral care, namely, the treatment of oral inflammation, namely, stomatitis; emetics; medicines for dental purposes, namely, pharmaceutical preparations for the treatment of gingivostomatitis, alveolar abscess, alveoloclasia; antacids; intestinal regulators, namely, gastro-intestinal treatment preparations; antiemetics; castor oil for medical purposes; tooth prophylactics, namely, material for stopping teeth; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations for the treatment of disease affecting uro-genitial and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives; medicated skin care preparations, pharmaceutical preparations for dermatics and for purulence; pharmaceutical preparations for the treatment of skin infection; antimicrobials for dermatologic use; astringents; anti-inflammatories; analgesics; emollients, namely, medicinal creams for skin care; hair remedies, namely, medicated hair care preparations; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements; chondroitin preparations; protein and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics; pharmaceutical preparations for conditions affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for activating cellular function; chlorophyll preparations in the nature of dietary supplements; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; medicated skin care preparations for treating physically caused lesions; pharmaceutical preparations for the treatment of heatstroke; radiation sickness treating agents; pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn and side effect of anticancer drugs; immunosuppresants; pharmaceutical preparations for chlorine-detoxication; pharmaceutical preparations for arsenic-detoxication; pharmaceutical preparations for benzol-detoxication; antibiotic preparations; erythromycin preparations; chioramphenicol preparations; colistin-polymixin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes; antitoxic sera; antitoxins, mixed biological preparations for medical purposes; preparations for biological tests for medical purposes; toxoids; vaccines; preparations for destroying parasites; anthelmintics; ointment bases of the drugs for skin diseases, namely, itching, injury, burn, keloid, dermatitis, eczema, skin ulcer, psoriasis; diagnostic preparations for medical and veterinary use; contrast media for use with X-ray equipment; diagnostic reagents for medical use; diagnostic media for bacteriological cultures; radio-isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides; insect-repellents; antiseptics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, June 6, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | KRINGLE PHARMA, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | KRINGLE PHARMA, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | KRINGLE PHARMA, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Friday, June 17, 2016 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, June 17, 2016 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, July 10, 2015 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Tuesday, June 23, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Tuesday, June 23, 2015 | INVALIDATION PROCESSED |
| Sunday, May 31, 2015 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, February 6, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, June 6, 2014 | CANCELLED SECTION 71 |
| Wednesday, January 13, 2010 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 5, 2009 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, February 5, 2008 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, February 4, 2008 | FINAL DISPOSITION PROCESSED |
| Wednesday, January 30, 2008 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 30, 2007 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 14, 2007 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 25, 2007 | NOTICE OF PUBLICATION |
| Tuesday, July 10, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, July 10, 2007 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 18, 2007 | AMENDMENT FROM APPLICANT ENTERED |
| Monday, June 18, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 7, 2007 | PAPER RECEIVED |
| Tuesday, April 24, 2007 | NON-FINAL ACTION MAILED |
| Monday, April 23, 2007 | NON-FINAL ACTION WRITTEN |
| Saturday, March 17, 2007 | AMENDMENT FROM APPLICANT ENTERED |
| Saturday, March 17, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 16, 2007 | ASSIGNED TO LIE |
| Wednesday, February 7, 2007 | PAPER RECEIVED |
| Saturday, January 13, 2007 | ATTORNEY REVIEW COMPLETED |
| Wednesday, December 20, 2006 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Thursday, December 7, 2006 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Wednesday, November 22, 2006 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, September 15, 2006 | REFUSAL PROCESSED BY IB |
| Tuesday, August 29, 2006 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, August 29, 2006 | REFUSAL PROCESSED BY MPU |
| Saturday, August 26, 2006 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, August 25, 2006 | NON-FINAL ACTION WRITTEN |
| Friday, August 11, 2006 | ASSIGNED TO EXAMINER |
| Friday, August 11, 2006 | NEW APPLICATION ENTERED IN TRAM |
| Thursday, August 10, 2006 | SN ASSIGNED FOR SECT 66A APPL FROM IB |